O	O	0	4	Cell	Cell	B-NP	NN	O	4	NMOD	O
O	O	4	5	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	5	13	specific	specific	I-NP	JJ	O	4	NMOD	O
O	O	14	25	differences	difference	I-NP	NNS	O	0	ROOT	O
O	O	26	28	in	in	B-PP	IN	O	4	NMOD	O
O	O	29	39	activation	activation	B-NP	NN	O	5	PMOD	O
O	O	40	42	of	of	B-PP	IN	O	6	NMOD	O
T19,T20	B-Entity,B-Entity	43	45	NF	NF	B-NP	NN	O	13	NMOD	O
T19,T20	I-Entity,I-Entity	45	46	-	-	B-NP	HYPH	O	13	NMOD	O
T19,T20	I-Entity,I-Entity	46	51	kappa	kappa	I-NP	NN	B-DNA	13	NMOD	B-DNA
T19,T20	I-Entity,I-Entity	52	53	B	B	I-NP	NN	I-DNA	13	NMOD	I-DNA
T19	I-Entity	54	64	regulatory	regulatory	I-NP	JJ	I-DNA	13	NMOD	I-DNA
T19	I-Entity	65	73	elements	element	I-NP	NNS	I-DNA	7	PMOD	I-DNA
O	O	74	76	of	of	B-PP	IN	O	13	NMOD	O
O	O	77	82	human	human	B-NP	JJ	B-DNA	17	NMOD	B-DNA
O	O	83	99	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	17	NMOD	I-DNA
O	O	100	105	virus	virus	I-NP	NN	I-DNA	21	NMOD	I-DNA
O	O	106	109	and	and	O	CC	I-DNA	21	NMOD	I-DNA
T21	B-Entity	110	114	beta	beta	B-NP	NN	I-DNA	21	NMOD	I-DNA
T21	I-Entity	115	125	interferon	interferon	I-NP	NN	I-DNA	21	NMOD	I-DNA
T21	I-Entity	126	135	promoters	promoter	I-NP	NNS	I-DNA	14	PMOD	I-DNA
O	O	136	138	by	by	B-PP	IN	O	6	NMOD	O
T1	B-Protein	139	144	tumor	tumor	B-NP	NN	B-protein	25	NMOD	B-protein
T1	I-Protein	145	153	necrosis	necrosis	I-NP	NN	I-protein	25	NMOD	I-protein
T1	I-Protein	154	160	factor	factor	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	160	161	.	.	O	.	O	4	P	O

O	O	163	168	Three	Three	B-NP	CD	O	2	NMOD	O
O	O	169	176	aspects	aspect	I-NP	NNS	O	18	SUB	O
O	O	177	179	of	of	B-PP	IN	O	2	NMOD	O
O	O	180	183	the	the	B-NP	DT	O	5	NMOD	O
O	O	184	195	involvement	involvement	I-NP	NN	O	3	PMOD	O
O	O	196	198	of	of	B-PP	IN	O	5	NMOD	O
T2	B-Protein	199	204	tumor	tumor	B-NP	NN	B-protein	9	NMOD	B-protein
T2	I-Protein	205	213	necrosis	necrosis	I-NP	NN	I-protein	9	NMOD	I-protein
T2	I-Protein	214	220	factor	factor	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	221	223	in	in	B-PP	IN	O	2	NMOD	O
O	O	224	229	human	human	B-NP	JJ	O	13	NMOD	O
O	O	230	246	immunodeficiency	immunodeficiency	I-NP	NN	O	13	NMOD	O
O	O	247	252	virus	virus	I-NP	NN	O	17	NMOD	O
O	O	253	254	(	(	O	(	O	16	DEP	O
O	O	254	257	HIV	HIV	B-NP	NN	O	16	DEP	O
O	O	257	258	)	)	O	)	O	13	NMOD	O
O	O	259	271	pathogenesis	pathogenesis	B-NP	NN	O	10	PMOD	O
O	O	272	276	were	be	B-VP	VBD	O	0	ROOT	O
O	O	277	285	examined	examine	I-VP	VBN	O	18	VC	O
O	O	285	286	.	.	O	.	O	18	P	O

T3	B-Protein	287	292	Tumor	Tumor	B-NP	NN	B-protein	4	NMOD	B-protein
T3	I-Protein	293	301	necrosis	necrosis	I-NP	NN	I-protein	4	NMOD	I-protein
T3	I-Protein	302	308	factor	factor	I-NP	NN	I-protein	4	NMOD	I-protein
T3	I-Protein	309	314	alpha	alpha	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	315	316	(	(	O	(	O	11	NMOD	O
T4	B-Protein	316	319	TNF	TNF	B-NP	NN	B-protein	11	NMOD	B-protein
T4	I-Protein	319	320	-	-	O	HYPH	O	8	P	O
T4	I-Protein	320	325	alpha	alpha	O	SYM	O	11	NMOD	O
O	O	325	326	)	)	O	)	O	8	DEP	O
O	O	327	331	mRNA	mRNA	B-NP	NN	O	11	NMOD	O
O	O	332	342	production	production	I-NP	NN	O	12	SUB	O
O	O	343	346	was	be	B-VP	VBD	O	0	ROOT	O
O	O	347	355	analyzed	analyze	I-VP	VBN	O	12	VC	O
O	O	356	358	by	by	B-PP	IN	O	13	VMOD	O
O	O	359	369	polymerase	polymerase	B-NP	NN	O	18	NMOD	O
O	O	370	375	chain	chain	I-NP	NN	O	18	NMOD	O
O	O	376	384	reaction	reaction	I-NP	NN	O	18	NMOD	O
O	O	385	398	amplification	amplification	I-NP	NN	O	14	PMOD	O
O	O	399	401	in	in	B-PP	IN	O	13	VMOD	O
O	O	402	411	monocytic	monocytic	B-NP	JJ	B-cell_line	22	NMOD	B-cell_line
O	O	412	416	U937	U937	I-NP	NN	I-cell_line	22	NMOD	I-cell_line
O	O	417	422	cells	cell	I-NP	NNS	I-cell_line	19	PMOD	I-cell_line
O	O	423	426	and	and	B-PP	CC	O	19	PMOD	O
O	O	427	429	in	in	B-PP	IN	O	19	PMOD	O
O	O	430	431	a	a	B-NP	DT	O	31	NMOD	O
O	O	432	443	chronically	chronically	I-NP	RB	B-cell_line	31	NMOD	B-cell_line
O	O	444	447	HIV	HIV	I-NP	NN	I-cell_line	31	NMOD	I-cell_line
O	O	448	456	infected	infected	I-NP	JJ	I-cell_line	31	NMOD	I-cell_line
O	O	457	461	U937	U937	I-NP	NN	I-cell_line	31	NMOD	I-cell_line
O	O	462	466	cell	cell	I-NP	NN	I-cell_line	31	NMOD	I-cell_line
O	O	467	471	line	line	I-NP	NN	I-cell_line	24	PMOD	I-cell_line
O	O	472	473	(	(	O	(	O	36	DEP	O
O	O	473	475	U9	U9	B-NP	NN	B-cell_line	35	NMOD	B-cell_line
O	O	475	476	-	-	B-NP	HYPH	I-cell_line	35	P	I-cell_line
O	O	476	480	IIIB	IIIB	I-NP	NN	I-cell_line	36	DEP	I-cell_line
O	O	480	481	)	)	O	)	O	31	NMOD	O
O	O	481	482	.	.	O	.	O	12	P	O

T5	B-Protein	483	486	TNF	TNF	B-NP	NN	B-protein	4	NMOD	B-protein
T5	I-Protein	486	487	-	-	O	HYPH	O	4	P	O
T5	I-Protein	487	492	alpha	alpha	O	SYM	B-RNA	4	NMOD	B-RNA
O	O	493	496	RNA	RNA	B-NP	NN	I-RNA	5	SUB	I-RNA
O	O	497	500	was	be	B-VP	VBD	O	11	VMOD	O
O	O	501	513	undetectable	undetectable	B-ADJP	JJ	O	5	PRD	O
O	O	514	516	in	in	B-PP	IN	O	6	AMOD	O
O	O	517	521	U937	U937	B-NP	NN	B-cell_line	9	NMOD	B-cell_line
O	O	522	527	cells	cell	I-NP	NNS	I-cell_line	7	PMOD	I-cell_line
O	O	527	528	,	,	O	,	O	11	P	O
O	O	529	536	whereas	whereas	O	IN	O	0	ROOT	O
O	O	537	538	a	a	B-NP	DT	O	15	NMOD	O
O	O	539	542	low	low	I-NP	JJ	O	15	NMOD	O
O	O	543	555	constitutive	constitutive	I-NP	JJ	O	15	NMOD	O
O	O	556	561	level	level	I-NP	NN	O	16	SUB	O
O	O	562	565	was	be	B-VP	VBD	O	11	VMOD	O
O	O	566	574	detected	detect	I-VP	VBN	O	16	VC	O
O	O	575	577	in	in	B-PP	IN	O	17	VMOD	O
O	O	578	580	U9	U9	B-NP	NN	B-cell_line	22	NMOD	B-cell_line
O	O	580	581	-	-	B-NP	HYPH	I-cell_line	22	NMOD	I-cell_line
O	O	581	585	IIIB	IIIB	I-NP	NN	I-cell_line	22	NMOD	I-cell_line
O	O	586	591	cells	cell	I-NP	NNS	I-cell_line	18	PMOD	I-cell_line
O	O	591	592	.	.	O	.	O	11	P	O

O	O	593	606	Paramyxovirus	Paramyxovirus	B-NP	NN	O	2	NMOD	O
O	O	607	616	infection	infection	I-NP	NN	O	3	SUB	O
O	O	617	624	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	625	626	a	a	B-NP	DT	O	11	NMOD	O
O	O	627	628	5	5	I-NP	CD	O	6	NMOD	O
O	O	628	629	-	-	I-NP	HYPH	O	4	P	O
O	O	630	632	to	to	B-PP	TO	O	10	AMOD	O
O	O	633	635	10	10	B-NP	CD	O	10	AMOD	O
O	O	635	636	-	-	I-NP	HYPH	O	10	AMOD	O
O	O	636	640	fold	fold	I-NP	JJ	O	11	NMOD	O
O	O	641	649	increase	increase	I-NP	NN	O	3	OBJ	O
O	O	650	652	in	in	B-PP	IN	O	11	NMOD	O
O	O	653	656	the	the	B-NP	DT	O	17	NMOD	O
O	O	657	663	steady	steady	I-NP	JJ	O	17	NMOD	O
O	O	663	664	-	-	I-NP	HYPH	O	17	NMOD	O
O	O	664	669	state	state	I-NP	NN	O	17	NMOD	O
O	O	670	675	level	level	I-NP	NN	O	12	PMOD	O
O	O	676	678	of	of	B-PP	IN	O	17	NMOD	O
T6	B-Protein	679	682	TNF	TNF	B-NP	NN	B-protein	22	NMOD	B-protein
T6	I-Protein	682	683	-	-	O	HYPH	O	22	NMOD	O
T6	I-Protein	683	688	alpha	alpha	B-NP	SYM	B-RNA	22	NMOD	B-RNA
O	O	689	692	RNA	RNA	I-NP	NN	I-RNA	18	PMOD	I-RNA
O	O	693	695	in	in	B-PP	IN	O	11	NMOD	O
O	O	696	698	U9	U9	B-NP	NN	B-cell_line	27	NMOD	B-cell_line
O	O	698	699	-	-	B-NP	HYPH	I-cell_line	27	NMOD	I-cell_line
O	O	699	703	IIIB	IIIB	I-NP	NN	I-cell_line	27	NMOD	I-cell_line
O	O	704	709	cells	cell	I-NP	NNS	I-cell_line	23	PMOD	I-cell_line
O	O	710	718	compared	compare	B-PP	VBN	O	3	VMOD	O
O	O	719	723	with	with	B-PP	IN	O	28	PMOD	O
O	O	724	728	U937	U937	B-NP	NN	B-cell_line	31	NMOD	B-cell_line
O	O	729	734	cells	cell	I-NP	NNS	I-cell_line	29	PMOD	I-cell_line
O	O	734	735	,	,	O	,	O	3	P	O
O	O	736	746	suggesting	suggest	B-VP	VBG	O	3	VMOD	O
O	O	747	751	that	that	B-SBAR	IN	O	33	VMOD	O
O	O	752	755	HIV	HIV	B-NP	NN	O	39	NMOD	O
O	O	755	756	-	-	B-NP	HYPH	O	39	P	O
O	O	756	764	infected	infect	I-NP	VBN	O	39	NMOD	O
O	O	765	774	monocytic	monocytic	I-NP	JJ	B-cell_type	39	NMOD	B-cell_type
O	O	775	780	cells	cell	I-NP	NNS	I-cell_type	40	SUB	I-cell_type
O	O	781	789	produced	produce	B-VP	VBD	O	34	SBAR	O
O	O	790	796	higher	high	B-NP	JJR	O	42	NMOD	O
O	O	797	803	levels	level	I-NP	NNS	O	40	OBJ	O
O	O	804	806	of	of	B-PP	IN	O	42	NMOD	O
T7	B-Protein	807	810	TNF	TNF	B-NP	NN	B-protein	46	NMOD	B-protein
T7	I-Protein	810	811	-	-	O	HYPH	O	46	P	O
T7	I-Protein	811	816	alpha	alpha	B-NP	SYM	O	43	PMOD	O
O	O	817	821	than	than	B-SBAR	IN	O	40	VMOD	O
O	O	822	825	did	do	B-VP	VBD	O	47	SBAR	O
O	O	826	832	normal	normal	B-NP	JJ	B-cell_type	50	NMOD	B-cell_type
O	O	833	838	cells	cell	I-NP	NNS	I-cell_type	48	OBJ	I-cell_type
O	O	839	844	after	after	B-PP	IN	O	48	VMOD	O
O	O	845	846	a	a	B-NP	DT	O	55	NMOD	O
O	O	847	856	secondary	secondary	I-NP	JJ	O	55	NMOD	O
O	O	857	862	virus	virus	I-NP	NN	O	55	NMOD	O
O	O	863	872	infection	infection	I-NP	NN	O	51	PMOD	O
O	O	872	873	.	.	O	.	O	3	P	O

O	O	874	877	The	The	B-NP	DT	O	2	NMOD	O
O	O	878	885	effects	effect	I-NP	NNS	O	10	SUB	O
O	O	886	888	of	of	B-PP	IN	O	2	NMOD	O
T8	B-Protein	889	892	TNF	TNF	B-NP	NN	B-protein	6	NMOD	B-protein
T8	I-Protein	892	893	-	-	O	HYPH	O	6	P	O
T8	I-Protein	893	898	alpha	alpha	B-NP	SYM	O	3	PMOD	O
O	O	899	901	on	on	B-PP	IN	O	2	NMOD	O
O	O	902	906	gene	gene	B-NP	NN	O	9	NMOD	O
O	O	907	917	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	918	922	were	be	B-VP	VBD	O	0	ROOT	O
O	O	923	931	examined	examine	I-VP	VBN	O	10	VC	O
O	O	932	934	by	by	B-PP	IN	O	11	VMOD	O
O	O	935	944	transient	transient	B-NP	JJ	O	15	NMOD	O
O	O	945	955	expression	expression	I-NP	NN	O	15	NMOD	O
O	O	956	962	assays	assay	I-NP	NNS	O	12	PMOD	O
O	O	963	968	using	use	B-VP	VBG	O	15	NMOD	O
O	O	969	977	reporter	reporter	B-NP	NN	B-DNA	20	NMOD	B-DNA
T9	B-Protein	978	993	chloramphenicol	chloramphenicol	I-NP	NN	I-DNA	20	NMOD	I-DNA
T9	I-Protein	994	1011	acetyltransferase	acetyltransferase	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	1012	1020	plasmids	plasmid	I-NP	NNS	I-DNA	16	OBJ	I-DNA
O	O	1021	1027	linked	link	B-VP	VBN	O	20	NMOD	O
O	O	1028	1030	to	to	B-PP	TO	O	21	VMOD	O
T22	B-Entity	1031	1041	regulatory	regulatory	B-NP	JJ	B-DNA	24	NMOD	B-DNA
T22	I-Entity	1042	1050	elements	element	I-NP	NNS	I-DNA	38	NMOD	I-DNA
O	O	1051	1055	from	from	B-PP	IN	O	24	NMOD	O
O	O	1056	1059	the	the	B-NP	DT	O	30	NMOD	O
T23	B-Entity	1060	1063	HIV	HIV	I-NP	NN	B-DNA	30	NMOD	B-DNA
T23	I-Entity	1064	1068	long	long	I-NP	JJ	I-DNA	30	NMOD	I-DNA
T23	I-Entity	1069	1077	terminal	terminal	I-NP	JJ	I-DNA	30	NMOD	I-DNA
T23	I-Entity	1078	1084	repeat	repeat	I-NP	NN	I-DNA	25	PMOD	I-DNA
O	O	1085	1086	(	(	O	(	O	33	DEP	O
T24	B-Entity	1086	1089	LTR	LTR	B-NP	NN	B-DNA	33	DEP	B-DNA
O	O	1089	1090	)	)	O	)	O	30	NMOD	O
O	O	1091	1094	and	and	O	CC	O	38	NMOD	O
O	O	1095	1098	the	the	B-NP	DT	O	38	NMOD	O
T10	B-Protein	1099	1103	beta	beta	I-NP	NN	B-DNA	38	NMOD	B-DNA
T10	I-Protein	1104	1114	interferon	interferon	I-NP	NN	I-DNA	38	NMOD	I-DNA
T25	B-Entity	1115	1123	promoter	promoter	I-NP	NN	I-DNA	22	PMOD	I-DNA
O	O	1123	1124	.	.	O	.	O	10	P	O

O	O	1125	1127	In	In	B-PP	IN	O	23	VMOD	O
O	O	1128	1132	U937	U937	B-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	1133	1136	and	and	I-NP	CC	O	7	NMOD	O
O	O	1137	1143	Jurkat	Jurkat	I-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	1144	1145	T	T	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	1146	1154	lymphoid	lymphoid	I-NP	JJ	I-cell_line	7	NMOD	I-cell_line
O	O	1155	1160	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	I-cell_line
O	O	1160	1161	,	,	O	,	O	23	P	O
O	O	1162	1165	the	the	B-NP	DT	O	10	NMOD	O
O	O	1166	1178	inducibility	inducibility	I-NP	NN	O	23	SUB	O
O	O	1179	1181	of	of	B-PP	IN	O	10	NMOD	O
O	O	1182	1185	the	the	B-NP	DT	O	15	NMOD	O
O	O	1186	1195	different	different	I-NP	JJ	O	15	NMOD	O
T26	B-Entity	1196	1202	hybrid	hybrid	I-NP	JJ	B-DNA	15	NMOD	B-DNA
T26	I-Entity	1203	1212	promoters	promoter	I-NP	NNS	I-DNA	11	PMOD	I-DNA
O	O	1213	1215	by	by	B-PP	IN	O	10	NMOD	O
T11	B-Protein	1216	1219	TNF	TNF	B-NP	NN	B-protein	22	NMOD	B-protein
T11	I-Protein	1219	1220	-	-	O	HYPH	O	22	NMOD	O
T11	I-Protein	1220	1225	alpha	alpha	B-NP	SYM	O	22	NMOD	O
O	O	1226	1228	or	or	O	CC	O	22	NMOD	O
O	O	1229	1236	phorbol	phorbol	B-NP	NN	O	22	NMOD	O
O	O	1237	1242	ester	ester	I-NP	NN	O	16	PMOD	O
O	O	1243	1249	varied	vary	B-VP	VBD	O	49	VMOD	O
O	O	1250	1252	in	in	B-PP	IN	O	23	VMOD	O
O	O	1253	1254	a	a	B-NP	DT	O	27	NMOD	O
O	O	1255	1259	cell	cell	I-NP	NN	O	27	NMOD	O
O	O	1260	1264	type	type	I-NP	NN	O	34	NMOD	O
O	O	1264	1265	-	-	O	HYPH	O	34	NMOD	O
O	O	1266	1269	and	and	O	CC	O	34	NMOD	O
O	O	1270	1278	promoter	promoter	B-NP	NN	O	31	NMOD	O
O	O	1279	1286	context	context	I-NP	NN	O	34	NMOD	O
O	O	1286	1287	-	-	B-NP	HYPH	O	34	NMOD	O
O	O	1287	1295	specific	specific	I-NP	JJ	O	34	NMOD	O
O	O	1296	1302	manner	manner	I-NP	NN	O	24	PMOD	O
O	O	1302	1303	;	;	O	:	O	49	P	O
O	O	1304	1307	the	the	B-NP	DT	O	37	NMOD	O
O	O	1308	1314	levels	level	I-NP	NNS	O	49	SUB	O
O	O	1315	1317	of	of	B-PP	IN	O	37	NMOD	O
O	O	1318	1322	gene	gene	B-NP	NN	O	40	NMOD	O
O	O	1323	1331	activity	activity	I-NP	NN	O	38	PMOD	O
O	O	1332	1334	of	of	B-PP	IN	O	40	NMOD	O
T27	B-Entity	1335	1337	NF	NF	B-NP	NN	B-protein	45	NMOD	B-protein
T27	I-Entity	1337	1338	-	-	B-NP	HYPH	I-protein	45	NMOD	I-protein
T27	I-Entity	1338	1343	kappa	kappa	I-NP	NN	I-protein	45	NMOD	I-protein
T27	I-Entity	1344	1345	B	B	I-NP	NN	I-protein	48	NMOD	I-protein
O	O	1345	1346	-	-	B-VP	HYPH	O	48	P	O
O	O	1346	1356	containing	contain	B-NP	VBG	O	48	NMOD	O
O	O	1357	1365	plasmids	plasmid	I-NP	NNS	B-DNA	41	PMOD	B-DNA
O	O	1366	1376	correlated	correlate	B-VP	VBD	O	0	ROOT	O
O	O	1377	1385	directly	directly	B-ADVP	RB	O	49	VMOD	O
O	O	1386	1390	with	with	B-PP	IN	O	49	VMOD	O
O	O	1391	1400	induction	induction	B-NP	NN	O	51	PMOD	O
O	O	1401	1403	of	of	B-PP	IN	O	52	NMOD	O
T28	B-Entity	1404	1406	NF	NF	B-NP	NN	B-protein	57	NMOD	B-protein
T28	I-Entity	1406	1407	-	-	B-NP	HYPH	I-protein	57	NMOD	I-protein
T28	I-Entity	1407	1412	kappa	kappa	I-NP	NN	I-protein	57	NMOD	I-protein
T28	I-Entity	1413	1414	B	B	I-NP	NN	I-protein	61	NMOD	I-protein
O	O	1415	1418	DNA	DNA	I-NP	NN	O	61	NMOD	O
O	O	1418	1419	-	-	B-NP	HYPH	O	61	NMOD	O
O	O	1419	1426	binding	binding	I-NP	NN	O	61	NMOD	O
O	O	1427	1435	activity	activity	I-NP	NN	O	53	PMOD	O
O	O	1435	1436	.	.	O	.	O	49	P	O

O	O	1437	1445	Although	Although	B-SBAR	IN	O	0	ROOT	O
O	O	1446	1449	the	the	B-NP	DT	O	6	NMOD	O
O	O	1450	1456	intact	intact	I-NP	JJ	O	6	NMOD	O
T12	B-Protein	1457	1461	beta	beta	I-NP	NN	B-DNA	6	NMOD	B-DNA
T12	I-Protein	1462	1472	interferon	interferon	I-NP	NN	I-DNA	6	NMOD	I-DNA
T29	B-Entity	1473	1481	promoter	promoter	I-NP	NN	I-DNA	7	SUB	I-DNA
O	O	1482	1485	was	be	B-VP	VBD	O	1	SBAR	O
O	O	1486	1490	only	only	I-VP	RB	O	7	VMOD	O
O	O	1491	1497	weakly	weakly	I-VP	RB	O	8	AMOD	O
O	O	1498	1508	stimulated	stimulate	I-VP	VBN	O	7	VC	O
O	O	1509	1511	by	by	B-PP	IN	O	10	VMOD	O
O	O	1512	1519	phorbol	phorbol	B-NP	NN	O	13	NMOD	O
O	O	1520	1525	ester	ester	I-NP	NN	O	30	SUB	O
O	O	1526	1528	or	or	I-NP	CC	O	17	NMOD	O
T13	B-Protein	1529	1532	TNF	TNF	I-NP	NN	B-protein	17	NMOD	B-protein
T13	I-Protein	1532	1533	-	-	O	HYPH	O	17	P	O
T13	I-Protein	1533	1538	alpha	alpha	B-NP	SYM	O	30	VMOD	O
O	O	1538	1539	,	,	O	,	O	30	P	O
O	O	1540	1549	multimers	multimer	B-NP	NNS	O	30	SUB	O
O	O	1550	1552	of	of	B-PP	IN	O	19	NMOD	O
O	O	1553	1556	the	the	B-NP	DT	O	29	NMOD	O
T30	B-Entity	1557	1562	PRDII	PRDII	I-NP	NN	B-DNA	29	NMOD	B-DNA
T30,T31	I-Entity,B-Entity	1563	1565	NF	NF	I-NP	NN	I-DNA	29	NMOD	I-DNA
T30,T31	I-Entity,I-Entity	1565	1566	-	-	B-VP	HYPH	I-DNA	29	NMOD	I-DNA
T30,T31	I-Entity,I-Entity	1566	1571	kappa	kappa	B-NP	NN	I-DNA	29	NMOD	I-DNA
T30,T31	I-Entity,I-Entity	1572	1573	B	B	I-NP	NN	I-DNA	29	NMOD	I-DNA
T30	I-Entity	1573	1574	-	-	O	HYPH	I-DNA	29	NMOD	I-DNA
T30	I-Entity	1574	1581	binding	bind	B-NP	VBG	I-DNA	29	NMOD	I-DNA
T30	I-Entity	1582	1588	domain	domain	I-NP	NN	I-DNA	20	PMOD	I-DNA
O	O	1589	1593	were	be	B-VP	VBD	O	11	SBAR	O
O	O	1594	1603	inducible	inducible	B-ADJP	JJ	O	30	PRD	O
O	O	1604	1606	by	by	B-PP	IN	O	31	AMOD	O
O	O	1607	1611	both	both	B-NP	DT	O	34	NMOD	O
O	O	1612	1618	agents	agent	I-NP	NNS	O	32	PMOD	O
O	O	1618	1619	.	.	O	.	O	1	P	O

T14	B-Protein	1620	1623	TNF	TNF	B-NP	NN	B-protein	3	NMOD	B-protein
T14	I-Protein	1623	1624	-	-	O	HYPH	O	3	P	O
T14	I-Protein	1624	1629	alpha	alpha	B-NP	SYM	O	4	SUB	O
O	O	1630	1633	was	be	B-VP	VBD	O	25	VMOD	O
O	O	1634	1638	able	able	B-ADJP	JJ	O	4	PRD	O
O	O	1639	1641	to	to	B-VP	TO	O	7	VMOD	O
O	O	1642	1650	increase	increase	I-VP	VB	O	5	AMOD	O
O	O	1651	1661	expression	expression	B-NP	NN	O	7	OBJ	O
O	O	1662	1664	of	of	B-PP	IN	O	8	NMOD	O
O	O	1665	1668	the	the	B-NP	DT	O	12	NMOD	O
T32	B-Entity	1669	1672	HIV	HIV	I-NP	NN	B-DNA	12	NMOD	B-DNA
T32	I-Entity	1673	1676	LTR	LTR	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	1677	1679	in	in	B-PP	IN	O	8	NMOD	O
O	O	1680	1681	T	T	B-NP	NN	B-cell_type	15	NMOD	B-cell_type
O	O	1682	1687	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	1687	1688	,	,	O	,	O	25	P	O
O	O	1689	1692	but	but	O	CC	O	25	VMOD	O
O	O	1693	1695	in	in	B-PP	IN	O	25	VMOD	O
O	O	1696	1705	monocytic	monocytic	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	1706	1711	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	1711	1712	,	,	O	,	O	25	P	O
T15	B-Protein	1713	1716	TNF	TNF	B-NP	NN	B-protein	24	NMOD	B-protein
T15	I-Protein	1716	1717	-	-	O	HYPH	O	24	P	O
T15	I-Protein	1717	1722	alpha	alpha	B-NP	SYM	O	25	SUB	O
O	O	1723	1726	did	do	B-VP	VBD	O	0	ROOT	O
O	O	1727	1730	not	not	I-VP	RB	O	25	VMOD	O
O	O	1731	1737	induce	induce	I-VP	VB	O	25	VC	O
O	O	1738	1741	the	the	B-NP	DT	O	30	NMOD	O
T33	B-Entity	1742	1745	HIV	HIV	I-NP	NN	B-DNA	30	NMOD	B-DNA
T33	I-Entity	1746	1749	LTR	LTR	I-NP	NN	I-DNA	27	OBJ	I-DNA
O	O	1750	1755	above	above	B-PP	IN	O	27	VMOD	O
O	O	1756	1757	a	a	B-NP	DT	O	34	NMOD	O
O	O	1758	1770	constitutive	constitutive	I-NP	JJ	O	34	NMOD	O
O	O	1771	1776	level	level	I-NP	NN	O	31	PMOD	O
O	O	1777	1779	of	of	B-PP	IN	O	34	NMOD	O
O	O	1780	1788	activity	activity	B-NP	NN	O	35	PMOD	O
O	O	1788	1789	.	.	O	.	O	25	P	O

O	O	1790	1794	This	This	B-NP	DT	O	2	NMOD	O
O	O	1795	1800	level	level	I-NP	NN	O	11	SUB	O
O	O	1801	1803	of	of	B-PP	IN	O	2	NMOD	O
T34	B-Entity	1804	1806	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T34	I-Entity	1806	1807	-	-	O	HYPH	I-protein	7	P	I-protein
T34	I-Entity	1807	1812	kappa	kappa	B-NP	NN	I-protein	7	NMOD	I-protein
T34	I-Entity	1813	1814	B	B	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	1814	1815	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	1815	1826	independent	independent	I-NP	JJ	O	10	NMOD	O
O	O	1827	1835	activity	activity	I-NP	NN	O	11	SUB	O
O	O	1836	1843	appears	appear	B-VP	VBZ	O	0	ROOT	O
O	O	1844	1846	to	to	I-VP	TO	O	13	VMOD	O
O	O	1847	1849	be	be	I-VP	VB	O	11	VMOD	O
O	O	1850	1860	sufficient	sufficient	B-ADJP	JJ	O	13	PRD	O
O	O	1861	1864	for	for	B-PP	IN	O	14	AMOD	O
O	O	1865	1870	virus	virus	B-NP	NN	O	17	NMOD	O
O	O	1871	1885	multiplication	multiplication	I-NP	NN	O	15	PMOD	O
O	O	1885	1886	,	,	O	,	O	11	P	O
O	O	1887	1892	since	since	B-SBAR	IN	O	11	VMOD	O
T16	B-Protein	1893	1896	TNF	TNF	B-NP	NN	B-protein	23	NMOD	B-protein
T16	I-Protein	1896	1897	-	-	O	HYPH	O	23	NMOD	O
T16	I-Protein	1897	1902	alpha	alpha	O	SYM	O	23	NMOD	O
O	O	1903	1912	treatment	treatment	B-NP	NN	O	24	SUB	O
O	O	1913	1916	had	have	B-VP	VBD	O	19	SBAR	O
O	O	1917	1919	no	no	B-NP	DT	O	26	NMOD	O
O	O	1920	1926	effect	effect	I-NP	NN	O	24	OBJ	O
O	O	1927	1929	on	on	B-PP	IN	O	24	VMOD	O
O	O	1930	1933	the	the	B-NP	DT	O	29	NMOD	O
O	O	1934	1942	kinetics	kinetic	I-NP	NNS	O	27	PMOD	O
O	O	1943	1945	of	of	B-PP	IN	O	29	NMOD	O
O	O	1946	1948	de	de	B-NP	FW	O	32	AMOD	O
O	O	1949	1953	novo	novo	I-NP	FW	O	45	NMOD	O
O	O	1954	1957	HIV	HIV	I-NP	NN	O	34	NMOD	O
O	O	1958	1962	type	type	I-NP	NN	O	41	NMOD	O
O	O	1963	1964	1	1	I-NP	CD	O	34	NMOD	O
O	O	1965	1966	(	(	O	(	O	40	DEP	O
O	O	1966	1969	HIV	HIV	B-NP	NN	O	39	SUB	O
O	O	1969	1970	-	-	B-NP	HYPH	O	39	P	O
O	O	1970	1971	1	1	I-NP	CD	O	40	DEP	O
O	O	1971	1972	)	)	O	)	O	34	NMOD	O
O	O	1973	1982	infection	infection	B-NP	NN	O	45	NMOD	O
O	O	1983	1986	and	and	O	CC	O	45	NMOD	O
O	O	1987	1992	viral	viral	B-NP	JJ	B-RNA	45	NMOD	B-RNA
O	O	1993	1996	RNA	RNA	I-NP	NN	I-RNA	45	NMOD	I-RNA
O	O	1997	2007	production	production	I-NP	NN	O	30	PMOD	O
O	O	2008	2010	in	in	B-PP	IN	O	45	NMOD	O
O	O	2011	2015	U937	U937	B-NP	NN	B-cell_line	48	NMOD	B-cell_line
O	O	2016	2021	cells	cell	I-NP	NNS	I-cell_line	46	PMOD	I-cell_line
O	O	2021	2022	.	.	O	.	O	11	P	O

O	O	2023	2030	However	However	B-ADVP	RB	O	11	VMOD	O
O	O	2030	2031	,	,	O	,	O	9	P	O
O	O	2032	2034	in	in	B-PP	IN	O	9	VMOD	O
O	O	2035	2041	Jurkat	Jurkat	B-NP	NN	B-cell_line	5	NMOD	B-cell_line
O	O	2042	2047	cells	cell	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	2047	2048	,	,	O	,	O	9	P	O
T17	B-Protein	2049	2052	TNF	TNF	B-NP	NN	B-protein	9	NMOD	B-protein
T17	I-Protein	2052	2053	-	-	O	HYPH	O	9	P	O
T17	I-Protein	2053	2058	alpha	alpha	B-NP	SYM	O	11	SUB	O
O	O	2059	2071	dramatically	dramatically	B-ADVP	RB	O	11	VMOD	O
O	O	2072	2080	enhanced	enhance	B-VP	VBD	O	0	ROOT	O
O	O	2081	2084	the	the	B-NP	DT	O	13	NMOD	O
O	O	2085	2091	spread	spread	I-NP	NN	O	11	OBJ	O
O	O	2092	2094	of	of	B-PP	IN	O	13	NMOD	O
O	O	2095	2098	HIV	HIV	B-NP	NN	O	17	NMOD	O
O	O	2098	2099	-	-	B-NP	HYPH	O	17	P	O
O	O	2099	2100	1	1	I-NP	CD	O	14	PMOD	O
O	O	2101	2108	through	through	B-PP	IN	O	13	NMOD	O
O	O	2109	2112	the	the	B-NP	DT	O	21	NMOD	O
O	O	2113	2117	cell	cell	I-NP	NN	O	21	NMOD	O
O	O	2118	2128	population	population	I-NP	NN	O	18	PMOD	O
O	O	2129	2132	and	and	O	CC	O	11	VMOD	O
O	O	2133	2142	increased	increase	B-VP	VBD	O	11	VMOD	O
O	O	2143	2148	viral	viral	B-NP	JJ	B-RNA	26	NMOD	B-RNA
O	O	2149	2152	RNA	RNA	I-NP	NN	I-RNA	26	NMOD	I-RNA
O	O	2153	2162	synthesis	synthesis	I-NP	NN	O	23	OBJ	O
O	O	2162	2163	,	,	O	,	O	11	P	O
O	O	2164	2174	indicating	indicate	B-VP	VBG	O	11	VMOD	O
O	O	2175	2179	that	that	B-SBAR	IN	O	28	VMOD	O
O	O	2180	2182	in	in	B-PP	IN	O	29	DEP	O
O	O	2183	2184	T	T	B-NP	NN	B-cell_type	32	NMOD	B-cell_type
O	O	2185	2190	cells	cell	I-NP	NNS	I-cell_type	36	NMOD	I-cell_type
O	O	2191	2194	HIV	HIV	I-NP	NN	O	36	NMOD	O
O	O	2194	2195	-	-	B-NP	HYPH	O	36	NMOD	O
O	O	2195	2196	1	1	I-NP	CD	O	36	NMOD	O
O	O	2197	2211	multiplication	multiplication	I-NP	NN	O	37	SUB	O
O	O	2212	2215	was	be	B-VP	VBD	O	30	SBAR	O
O	O	2216	2226	stimulated	stimulate	I-VP	VBN	O	37	VC	O
O	O	2227	2229	by	by	B-PP	IN	O	38	VMOD	O
T18	B-Protein	2230	2233	TNF	TNF	B-NP	NN	B-protein	43	NMOD	B-protein
T18	I-Protein	2233	2234	-	-	O	HYPH	O	43	NMOD	O
T18	I-Protein	2234	2239	alpha	alpha	B-NP	SYM	O	43	NMOD	O
O	O	2240	2249	treatment	treatment	I-NP	NN	O	39	PMOD	O
O	O	2249	2250	.	.	O	.	O	11	P	O
